Novo Nordisk and AstraZeneca seek tonic from key drug trials

LONDON (Reuters) - Novo Nordisk and AstraZeneca, two drugmakers whose financial outlooks disappointed investors last month, are both hoping for a boost in the coming weeks from results of two closely watched clinical trials.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro